Rob Casper

Rob Casper has a strong background in clinical operations, with experience spanning various roles and companies. Rob is currently the Vice President of Clinical Operations at Adaptive Phage Therapeutics, a position they started in March 2022. Prior to this, from January 2020 to February 2022, Rob served as Vice President of Clinical Operations at Altimmune, Inc. Their experience also includes roles such as Senior Director of Clinical Operations at Kolon TissueGene, Inc. from September 2016 to January 2020, Senior Director of Clinical Operations at Symbiomix Therapeutics, LLC from February 2015 to September 2016, and Director of Clinical Operations at Cerecor Inc. from February 2012 to January 2015. Earlier in their career, Rob worked as a Project Manager at SNBL Clinical Pharmacology Center from February 2009 to March 2011 and as a Clinical Trials Manager at Alba Therapeutics from December 2006 to February 2009.

Rob Casper has a Bachelor of Science (B.S.) degree in Psychology from Towson University. Rob also holds two Master of Science (M.S.) degrees, one in Developmental Psychology and another in Clinical Counseling and Applied Psychology, both from The Johns Hopkins University. However, no specific information about the start and end years of these educational pursuits is provided.